Prediction of tumor regression grade in far-advanced gastric cancer after preoperative immuno-chemotherapy using dual-energy CT-derived extracellular volume fraction-Reference-Cited by-同舟云学术

Prediction of tumor regression grade in far-advanced gastric cancer after preoperative immuno-chemotherapy using dual-energy CT-derived extracellular volume fraction

Published:2024-07-09 Issue: Volume: Page:
ISSN:1432-1084
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Chen Yong,Jiang Jinling,Yan Chao,Jiang Jiang,Shi Bowen,Xu Zhihan,Yuan Fei,Zhang Huan,Zhang Jun

Funder

National Natural Science Foundation of China

Collaborative Innovation Cluster Project of Shanghai Municipal Health Commission

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00330-024-10737-0.pdf

Reference40 articles.

1. Wang L, Zhu L, Yan J et al (2023) CT-based radiomic acore: a risk stratifier in far-advanced gastric cancer patients. Acad Radiol 30:S220–S229. https://doi.org/10.1016/j.acra.2022.12.034

2. Wang F, Zhang X, Tang L et al (2023) The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer Commun 44:127–172. https://doi.org/10.1002/cac2.12516

3. Al-Batran S-E, Homann N, Pauligk C et al (2019) Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet 393:1948–1957. https://doi.org/10.1016/S0140-6736(18)32557-1

4. Mieno H, Yamashita K, Hosoda K et al (2017) Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer. Surg Today 47:1249–1258. https://doi.org/10.1007/s00595-017-1512-z

5. Jiang Q, Liu W, Zeng X et al (2023) Safety and efficacy of tislelizumab plus chemotherapy versus chemotherapy alone as neoadjuvant treatment for patients with locally advanced gastric cancer: real-world experience with a consecutive patient cohort. Front Immunol 14:1122121. https://doi.org/10.3389/fimmu.2023.1122121